281 related articles for article (PubMed ID: 591813)
1. A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity.
Jordan VC; Collins MM; Rowsby L; Prestwich G
J Endocrinol; 1977 Nov; 75(2):305-16. PubMed ID: 591813
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships.
Allen KE; Clark ER; Jordan VC
Br J Pharmacol; 1980; 71(1):83-91. PubMed ID: 7470748
[TBL] [Abstract][Full Text] [Related]
3. The binding of [3H]-oestradiol-17 beta in the immature rat uterus during the sequential administration of non-steroidal anti-oestrogens.
Jordan VC; Naylor KE
Br J Pharmacol; 1979 Feb; 65(2):167-73. PubMed ID: 760895
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and mice.
Nishino Y; Schneider MR; Michna H; von Angerer E
J Endocrinol; 1991 Sep; 130(3):409-14. PubMed ID: 1834757
[TBL] [Abstract][Full Text] [Related]
5. [The elucidation of the antiestrogen and antitumoral mechanisms of tamoxifen].
Borgna JL
Bull Cancer; 1994 Jan; 81(1):29-37. PubMed ID: 7949581
[TBL] [Abstract][Full Text] [Related]
6. Subcellular effects of monohydroxytamoxifen in the rat uterus: steroid receptors and mitosis.
Dix CJ; Jordan VC
J Endocrinol; 1980 Jun; 85(3):393-404. PubMed ID: 7411007
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus.
Wakeling AE; O'Connor KM; Newboult E
J Endocrinol; 1983 Dec; 99(3):447-53. PubMed ID: 6644235
[TBL] [Abstract][Full Text] [Related]
8. Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens.
Wakeling AE; Valcaccia B
J Endocrinol; 1983 Dec; 99(3):455-64. PubMed ID: 6644236
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
Jordan VC; Gosden B
Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
[TBL] [Abstract][Full Text] [Related]
10. Interaction of spironolactone with oestradiol receptors in cytosol.
Levy J; Burshell A; Marbach M; Afllalo L; Glick SM
J Endocrinol; 1980 Mar; 84(3):371-9. PubMed ID: 7391714
[TBL] [Abstract][Full Text] [Related]
11. Dose-related effects of non-steroidal antioestrogens nad oestrogens on the measurement of cytoplasmic oestrogen receptors in the rat and mouse uterus.
Jordan VC; Rowsby L; Dix CJ; Prestwich G
J Endocrinol; 1978 Jul; 78(1):71-81. PubMed ID: 681874
[TBL] [Abstract][Full Text] [Related]
12. Study of the in-vivo antioestrogenic action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), a novel intracellular histamine antagonist and antioestrogen binding site ligand.
Brandes LJ; Hogg GR
J Reprod Fertil; 1990 May; 89(1):59-67. PubMed ID: 2374133
[TBL] [Abstract][Full Text] [Related]
13. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
Jordan VC; Gosden B
J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
[TBL] [Abstract][Full Text] [Related]
14. Novel antioestrogens without partial agonist activity.
Wakeling AE; Bowler J
J Steroid Biochem; 1988 Oct; 31(4B):645-53. PubMed ID: 3199810
[TBL] [Abstract][Full Text] [Related]
15. Effect of oestradiol benzoate, tamoxifen and monohydroxytamoxifen on immature rat uterine progesterone receptor synthesis and endometrial cell division.
Jordan VC; Dix CJ
J Steroid Biochem; 1979 Jul; 11(1A):285-91. PubMed ID: 491598
[No Abstract] [Full Text] [Related]
16. Binding of [3H] monohydroxytamoxifen in ovarian carcinoma.
Holt JA; Jordan VC; Tate AC; Lorincz MA
Br J Obstet Gynaecol; 1983 Aug; 90(8):751-8. PubMed ID: 6882707
[TBL] [Abstract][Full Text] [Related]
17. Changes in the subcellular distribution of the rat uterus oestrogen receptor as induced by oestradiol, tamoxifen and ZD 182,780.
Mendes AF; Caramona MM; Lopes MC
J Pharm Pharmacol; 1996 Mar; 48(3):302-5. PubMed ID: 8737058
[TBL] [Abstract][Full Text] [Related]
18. Estrogen- and antiestrogen-induced ornithine decarboxylase activity and uterine growth in the rat.
Branham WS; Leamons ML; Sheehan DM
J Steroid Biochem; 1988 Feb; 29(2):153-9. PubMed ID: 3347055
[TBL] [Abstract][Full Text] [Related]
19. Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.
Dix CJ; Jordan VC
Endocrinology; 1980 Dec; 107(6):2011-20. PubMed ID: 7191796
[TBL] [Abstract][Full Text] [Related]
20. Steroidal pure antioestrogens.
Wakeling AE; Bowler J
J Endocrinol; 1987 Mar; 112(3):R7-10. PubMed ID: 3559447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
